Skip Navigation


JAC Advance Access originally published online on November 5, 2004
Journal of Antimicrobial Chemotherapy 2004 54(6):1035-1039; doi:10.1093/jac/dkh469
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
54/6/1035    most recent
dkh469v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dias, R.
Right arrow Articles by Caniça, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dias, R.
Right arrow Articles by Caniça, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

JAC vol.54 no.6 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved

Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14

Ricardo Dias and Manuela Caniça*

Antibiotic Resistance Unit, Centre of Bacteriology, National Institute of Health Dr. Ricardo Jorge, Av. Padre Cruz, 1649–016 Lisboa, Portugal

* Corresponding author. Tel: +351-217519246; Fax: +351-217519246; Email: manuela.canica{at}insa.min-saude.pt

Objectives: To study the phenotype and phylogenetic relatedness of invasive Streptococcus pneumoniae strains isolated in Portugal.

Methods: A total of 614 invasive S. pneumoniae strains, isolated in Portugal from 1999 to the first 6 months of 2002, were characterized using serotyping and antimicrobial susceptibility testing. National outpatient sale data for macrolides were compared with erythromycin resistance. We investigated the main clonal lineages from erythromycin-resistant strains of serotype 14 by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST).

Results: The emergence of erythromycin-resistant strains correlated well with the usage of azithromycin in Portugal during the period of the study (r=0.900, P=0.001). Serotype 14 made the largest contribution to this emergence. We found two clonal complexes (CC) among erythromycin-resistant strains: CC1 was formed by three sequence types (ST), ST156, ST143 and ST1042, and CC2 by ST15 and ST9. All STs described, except ST1042, are putative founders of clonal groups or subgroups from serotype 14 as defined in the pneumococcal MLST database.

Conclusions: This study suggests that macrolides usage is an important factor enhancing the spread of invasive erythromycin-resistant S. pneumoniae clones in Portugal. The study also makes a contribution to the understanding of spread of erythromycin-resistant clones in an international context.

Keywords: pneumococci , macrolide resistance , pulsed-field gel electrophoresis , multilocus sequence typing , international clones


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
L. Siira, M. Rantala, J. Jalava, A. J. Hakanen, P. Huovinen, T. Kaijalainen, O. Lyytikainen, and A. Virolainen
Temporal Trends of Antimicrobial Resistance and Clonality of Invasive Streptococcus pneumoniae Isolates in Finland, 2002 to 2006
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 2066 - 2073.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
R. Isozumi, Y. Ito, T. Ishida, M. Osawa, T. Hirai, I. Ito, K. Maniwa, M. Hayashi, H. Kagioka, M. Hirabayashi, et al.
Genotypes and Related Factors Reflecting Macrolide Resistance in Pneumococcal Pneumonia Infections in Japan
J. Clin. Microbiol., May 1, 2007; 45(5): 1440 - 1446.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. V. Hawkyard and R. J. Koerner
The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks
J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Ardanuy, A. Fenoll, S. Berron, L. Calatayud, J. Linares, and the Spanish Pneumococcal Infection Study Network
Increase of the M Phenotype among Erythromycin-Resistant Streptococcus pneumoniae Isolates from Spain Related to the Serotype 14 Variant of the Spain9V-3 Clone
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3162 - 3165.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. Dias, D. Louro, the Antimicrobial Resistance Surveillance Program, and M. Canica
Antimicrobial Susceptibility of Invasive Streptococcus pneumoniae Isolates in Portugal over an 11-Year Period
Antimicrob. Agents Chemother., June 1, 2006; 50(6): 2098 - 2105.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. J. Farrell and D. Felmingham
The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae
J. Antimicrob. Chemother., October 1, 2005; 56(4): 795 - 797.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.